Published in:
01-12-2019 | Lymphoma | Original Article
The clinicopathological characteristics of Kimura disease in Chinese patients
Authors:
Xuehan Zhang, Yang Jiao
Published in:
Clinical Rheumatology
|
Issue 12/2019
Login to get access
Abstract
Introduction
Kimura disease (KD) is a rare idiopathic inflammatory disorder of unknown etiology. Unusual presentations of KD might cause diagnostic difficulty or be misdiagnosed as malignancy if clinical suspicion is insufficiently high. Here, we aimed to determine the clinicopathological features of Chinese KD patients to reveal further insights into the natural history and treatment of this disease.
Method
The clinical data of 46 cases of KD diagnosed at Peking Union Medical College Hospital from January 1980 to December 2018 were analyzed retrospectively through case record review.
Results
Of 46 cases, 40 were male and six were female. The age at onset ranged from 2 to 56 years (median 27 years). All patients presented with either single (26.1%) or multi-focal (73.9%) subcutaneous masses. Twenty-nine (63.0%) cases presented with head and neck subcutaneous masses, and 9 cases (19.6%) involved different parts of the body. Parotid, submandibular, and lacrimal gland involvement occurred in 17 (37.0%), 3 (6.5%), and 2 cases (4.3%), respectively. Nephrotic syndrome was present in three cases (6.5%), and thromboembolism was present in five cases (10.9%). During follow-up, thirteen patients (13/28, 46.4%) relapsed over 1–13 years (median 8.5 years). The recurrence rate in patients receiving corticosteroids, surgery, and combined surgery and radiotherapy was 30.8%, 66.7%, and 50.0%, respectively. One patient was diagnosed with T cell lymphoma 1 year after diagnosis of KD.
Conclusions
KD is characterized by subcutaneous masses but it is also a systemic disease. Given the high rate of recurrence and reported association with lymphoma, patients require careful long-term follow-up.
Key Points • Kimura disease (KD) is a rare inflammatory disorder of unknown etiology that is endemic in Asia. • Clinicians must regard and manage KD as a systemic disease. • There is no consensus on optimal treatments and further studies are necessary to improve outcomes. • Given the high rate of recurrence and reported association with lymphoma, patients require careful long-term follow-up. |